Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orifice Medical was a Swedish medical technology company that specialized in the development and commercialization of innovative devices for the treatment of epistaxis, or nosebleeds. The company's flagship product, the Stas nasal packing device, was designed to provide a more effective and comfortable solution for patients compared to traditional nasal tampons. Headquartered in Ystad, Sweden, Orifice Medical focused on addressing unmet needs in the ear, nose, and throat (ENT) and emergency medicine markets. The Stas device featured a unique design that allowed for easy insertion and removal while maintaining consistent pressure to achieve hemostasis. In April 2013, Orifice Medical was acquired by Stryker Corporation, a major global medical technology firm. The acquisition integrated Orifice Medical's nasal packing technology into Stryker's ENT business unit, expanding their portfolio of surgical and emergency care products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orifice Medical.